Alantra advises Bansk Group on its acquisition of BYOMA

Sep 2025

Buy-side advisory

New York, London – Alantra acted as buy-side advisor to Bansk Group, a consumer-focused private investment firm dedicated to building distinctive consumer brands, in its agreement to acquire a majority stake in BYOMA, a fast-growing science-backed, solution-focused skin health brand, from Yellow Wood Partners.

Founded in 2019, Bansk Group is a New York-based private investment firm focused on investing in and building distinctive consumer brands. With over $3bn in assets under management, the firm partners with differentiated brands across four primary consumer categories: personal care, consumer health, food & beverage, and household products.

Founded in 2022, BYOMA has become one of the fastest-growing skincare brands globally due to its clinically proven solutions and prestige formulas offered at an accessible price point.

Rusty Ray, Managing Partner at Alantra, said: “We’re pleased to have advised Bansk on their strategic investment in BYOMA. Our team’s deep understanding of the global consumer health and beauty sector, combined with best-in-class execution skills, enabled us to find the best fit and reach a favorable agreement for all sides.”

This transaction further reinforces Alantra’s leadership in the consumer health and beauty space, where the team has advised on deals for nearly $3bn in aggregate value over the past 12 months. Recent transactions include the sales of Medik8 and Dr.G to L’Oréal, the divestment of Venture Life’s CDMO operations to BioDue, and the sale of Florachem to Tradebe, and the divestment of Perrigo Company plc’s European dermatology and lifestyle brands portfolio to DCC plc.